ESC Congress 2003: Stem cell therapy for myocardial repair & regenerationSeptember 01, 2003IMPORTANT: This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology Heart attack and the resulting heart failure is still one of the leading causes of death in the western world. Therefore, new theraepeutical approaches to restore damaged heart tissue are indispensable. Prof. Hescheler's research group has been working with murine embryonic stem cells for over 14 years now and was the first group worldwide to obviously measure physiological functions on embryonic stem cells. Recently his group demonstrated that cardiac precursor cells, especially differentiated out of pluripotent embryonic stem cells and injected in infarcted heart tissue, are able to build up new functioning heart muscle tissue. Embryonic stem cells can differentiate into nearly 200 different tissues. The main focus in his institute in Cologne is placed on the special development of so called cardiac precursor cells, "fore-runners" of differentiated, adult heart muscle cells. But how can we manage to lead many early embryonic stem cells on a physiological way to become fresh functioning heart cells? For this reason many molecular biological steps are necessary, including some genetic "tricks". At first a special protein-promotor is combined, which only works in cardiac precursor cells, with a green fluoescent protein, which stems from an atlantic jellyfish. If a cardiac precursor cell develops, this cell can be identifed by its green colour in the fluorescent microscope. Furthermore to this "genetic double-construct" a gene is bound, which makes the cardiac precursor cells resistant against special antibiotics. If the antibiotics are then given into the cell suspension, only cardiac precursor cells survive. In a mouse model a heart-attack-like damage by cryoinfarction is induced and the prepared cells injected into the infarcted area. After two weeks the heart is examined and wonderful green fluorescent tissue can be found, where before only dead material had been. The physiological engraftment of the cells can be by different investigations such as echocardiography, heart-catheterization and many cellular processes. Even better: a significant benefit in the survival rate of infarcted and then cell-transplanted mice compared to animals without the transplantation can be proven. Due to the promising results, the same will be performed on human embryonic stem cells. Prof. Hescheler's group is one of three in Germany, found to be ethically sound and allowed by the government to import human embryonic stem cells for scientific purposes. Professor Dr. med. Jürgen Hescheler | |||||||||||||||||||||
|
Related Stem Cells News Articles Small protein may have big role in making more bone and less fat A small protein may have a big role in helping you make more bone and less fat, researchers say. Researchers link early stem cell mutation to autism In a breakthrough scientific study published today in the Proceedings of the National Academy of Sciences, scientists at the Burnham Institute for Medical Research have shown that neural stem cell development may be linked to Autism. How to build a plant Walking through a tropical or temperate forest immediately impresses us with the myriad forms and soaring structures of the plant world, but our knowledge of how plants are actually built, cell by cell, is still incomplete. Nerve cells derived from stem cells and transplanted into mice may lead to improved brain treatments Scientists at the Burnham Institute for Medical Research have, for the first time, genetically programmed embryonic stem (ES) cells to become nerve cells when transplanted into the brain, according to a study published today in The Journal of Neuroscience. New source of heart stem cells discovered Researchers at Children's Hospital Boston are continuing to document the heart's earliest origins. Now, they have pinpointed a new, previously unrecognized group of stem cells that give rise to cardiomyocytes, or heart muscle cells. Penn researchers find key developmental pathway activates lung stem cells Researchers from the University of Pennsylvania School of Medicine found that the activation of a molecular pathway important in stem cell and developmental biology leads to an increase in lung stem cells. Harnessing this knowledge could help develop therapies for lung-tissue repair after injury or disease. Ability to track stem cells in tumors could advance cancer treatments Using noninvasive molecular imaging technology, a method has been developed to track the location and activity of mesenchymal stem cells (MSCs) in the tumors of living organisms. Wealth of genomic hotspots discovered in embryonic stem cells In a paper published in Cell on June 13, 2008, Singapore scientists at the Genome Institute of Singapore (GIS) and the National University of Singapore (NUS) unveil an atlas that showing the location of "genomic hotspots" of essential protein "switches" (transcription factors) that are critical for maintaining the embryonic stem (ES) cell state. 'HiCy' drug regimen reverses ms symptoms in selected patients A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report. Human stem cells show promise against fatal children's diseases Scientists have used human stem cells to dramatically improve the condition of mice with a neurological condition similar to a set of diseases in children that are invariably fatal, according to an article in the June issue of the journal Cell Stem Cell. More Stem Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||